Latest Financials News

Vintage Energy reported a 13% drop in quarterly sales revenue to $0.78 million, driven by lower gas production, while progressing a strategic acquisition to consolidate its Southern Flank Joint Ventures.

Actinogen Medical has completed enrolment for its pivotal XanaMIA Alzheimer's trial ahead of schedule, with a positive interim analysis supporting continuation. The company is gearing up for an open-label extension and advancing commercial and partnership strategies.

Stavely Minerals is advancing its 2026 Scoping Study for the Stavely Copper-Gold Project, targeting a significant production scale boosted by strong copper, gold, and silver prices. The company aims to outline a pathway to over 10 years of mine life with a mid-year study delivery.

Native Mineral Resources Holdings Limited reported a modest operating cash outflow in December 2025 but expects improved liquidity following recent gold sales and a $3 million convertible note raise.

Emu NL has reported promising visible copper sulphide mineralisation from its maiden drilling at Fiery Creek, advancing its Georgetown copper-gold project. Meanwhile, the company navigates leadership changes and governance reviews amid ongoing exploration.

BSA Limited reported a mixed Q2 FY2026 with improved EBITDA margins and completed restructuring, yet faces ongoing risks from lost contracts and uncertain second-half profitability.

Cosmo Metals has completed its first drilling program at Spring Creek in NSW after nearly 30 years, revealing high-grade gold mineralisation and identifying a new antimony-rich corridor, supported by government grants to advance exploration.

Native Mineral Resources reported steady gold production at its Blackjack operations, completed key plant upgrades, and progressed joint ventures, supported by a $3 million convertible note raise.

Charger Metals NL has retained 100% ownership of its Lake Johnston Lithium and Gold Project after Rio Tinto Exploration withdrew from their farm-in agreement. The company also reported a maiden lithium resource at Medcalf and uncovered significant high-grade gold intercepts at the Xmas Gold Discovery.

Biotron Limited has successfully closed its fully subscribed rights issue, raising $1.52 million, and completed the acquisition of Sedarex Limited, positioning itself for growth in its diversified biotech portfolio.

Alterity Therapeutics has bolstered its Phase 2 data for ATH434 in Multiple System Atrophy and is advancing regulatory plans for a pivotal Phase 3 trial, supported by a robust cash position of A$49.2 million.

KGL Resources has secured A$11 million to accelerate development at its Jervois Copper-Silver-Gold Project, buoyed by soaring commodity prices and fresh leadership appointments. The company is progressing construction readiness and optimisation efforts while engaging with funding partners.